Additionally, the company reported fiscal year operating income as $357 million, an adjusted operating income increase of 7 percent to $1 billion, an increase in cash from operations by 32 percent, and a free cash flow improvement to $135 million for the fiscal year.
Biomet reported a net loss of $14.5 million during the 2010 fiscal year as compared to a net loss of $170.9 million during the previous fiscal year.
Special items before tax were recorded as $132 million during the fourth quarter of the 2010 fiscal year and include $93.5 million of non-cash amortization and depreciation expense related to the merger. The further cost is primarily related to the $15.9 million associated with operational improvement initiatives and stock compensation expense.
Read the news release on Biomet financial results.
Read other coverage on Biomet:
– Biomet 3Q 2010 Net Sales Up 9%, Driven By Sales Growth for Orthopedic Devices
– Biomet Announces 8% Increase in Net Sales for FY2010 Q2
– Biomet Sales Yield $630M for Quarter
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
